Julie Ehlers

Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.

Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.

AI chatbots can sometimes provide accurate information about cancers, but these tools have significant limitations.